Marijuana Use in Adults Living with Sickle Cell Disease
Open Access
- 1 July 2018
- journal article
- research article
- Published by SAGE Publications in Cannabis & Cannabinoid Research
- Vol. 3 (1) , 162-165
Abstract
Introduction: Legal access to marijuana, most frequently as “medical marijuana,” is becoming more common in the United States, but most states do not specify sickle cell disease as a qualifying condition. We were aware that some of our patients living with sickle cell disease used illicit marijuana, and we sought more information about this. Materials and Methods: We practice at an urban, academic medical center and provide primary, secondary, and tertiary care for ∼130 adults living with sickle cell disease. We surveyed our patients with a brief, anonymous, paper-and-pen instrument. We reviewed institutional records for clinically driven urine drug testing. We tracked patient requests for certification for medical marijuana. Results: Among 58 patients surveyed, 42% reported marijuana use within the past 2 years. Among users, most endorsed five medicinal indications; a minority reported recreational use. Among 57 patients who had at least one urine drug test, 18% tested positive for cannabinoids only, 12% tested positive for cocaine and/or phencyclidine only, and 5% tested positive for both cannabinoids and cocaine/phencyclidine. Subsequent to these studies, sickle cell disease became a qualifying condition for medical marijuana in our state. In the interval ∼1.5 years, 44 patients have requested certification. Conclusion: Our findings and those of others create a rationale for research into the possible therapeutic effects of marijuana or cannabinoids, the presumed active constituents of marijuana, in sickle cell disease. Explicit inclusion of sickle cell disease as a qualifying condition for medical marijuana might reduce illicit marijuana use and related risks and costs to both persons living with sickle cell disease and society.Keywords
This publication has 12 references indexed in Scilit:
- National Estimates of Marijuana Use and Related Indicators — National Survey on Drug Use and Health, United States, 2002–2014Morbidity and Mortality Weekly Report, 2016
- Medical Marijuana Laws Reduce Prescription Medication Use In Medicare Part DHealth Affairs, 2016
- Medical Cannabis Use Is Associated With Decreased Opiate Medication Use in a Retrospective Cross-Sectional Survey of Patients With Chronic PainThe Journal of Pain, 2016
- Daily home opioid use in adults with sickle cell disease: The PiSCES projectJournal of Opioid Management, 2015
- Medical Cannabis Laws and Opioid Analgesic Overdose Mortality in the United States, 1999-2010JAMA Internal Medicine, 2014
- Pain-related behaviors and neurochemical alterations in mice expressing sickle hemoglobin: modulation by cannabinoidsBlood, 2010
- Daily Assessment of Pain in Adults with Sickle Cell DiseaseAnnals of Internal Medicine, 2008
- The prevalence of marijuana smoking in young adults with sickle cell disease: a longitudinal studyWest Indian Medical Journal, 2006
- Cannabis use in sickle cell disease: a questionnaire studyBritish Journal of Haematology, 2005
- Urine drug testing in pain medicineJournal of Pain and Symptom Management, 2004